Results 141 to 150 of about 44,684 (213)

Differential DNA methylation in infants with IgE- and non-IgE-mediated cow's milk allergy and its association with acquired tolerance. [PDF]

Front Immunol
López-Gómez R, Gil-Martínez M, Ladrón-Guevara A, Rodrigo-Muñoz JM, Lorente-Sorolla C, Rodríguez-González D, García de Castro Z, Guillén-Sánchez G, Serrano-Santiago A, Mirasierra-Pérez R, Cañas JA, Del Río Camacho G, Del Pozo V.   +12 more
europepmc   +1 more source

Recovery from symptoms using an extensively hydrolyzed formula with synbiotic in infants with presumed cow's milk allergy. [PDF]

J Pediatr Gastroenterol Nutr
Lemoine A, Villard-Truc F, Ait Mohamed Amar I, Payot F.   +3 more
europepmc   +1 more source

Oral immunotherapy for cow's milk allergy in children: a systematic review and meta-analysis. [PDF]

Front Immunol
Wang Y, Liu S, Lu M, Guo J, Lv C, Huang L.   +5 more
europepmc   +1 more source

Research Priorities for Children With Food Allergy: A UK James Lind Alliance Priority Setting Partnership

Clinical &Experimental Allergy, EarlyView.
The UK childhood food allergy James Lind Alliance Priority Setting Partnership collaboratively identified the most important research priorities highlighting the breadth of research required to improve the prevention, diagnosis, treatment and broader impacts of food allergy on those directly impacted. These provide a clear, stakeholder‐driven agenda to
Roxanne M. Parslow, Farhad Shokraneh, Sara J. Brown, Mary Feeney, Graham Roberts, Hora Soltani, Joanne Walsh, Amy Dobson, Emma Vaughan, Deborah Marriage, Suzi Holland, Mary Kelly, Holly Shaw, Alicia Kennedy, Eden Byrne, Liliana Jackson, Gail Jackson, Lauren Gluyas, Jonathan Gower, Alyson Huntley, Matthew J. Ridd   +20 more
wiley   +1 more source

Emerging Paediatric Uses of Dupilumab Beyond Approvals

Clinical &Experimental Allergy, EarlyView.
Dupilumab, through IL‐4Rα blockade, shows promising efficacy beyond approved indications in paediatric diseases driven by T2 inflammation. Emerging evidence—mainly from small studies—supports improvements in disease severity and quality of life, highlighting its potential as a targeted, steroid‐sparing therapy while underscoring the need for ...
Simone Foti Randazzese, Anna Calamita, Diletta D'Angelo, Alessia Marseglia, Esther Mesa Lombardero, Sara Pedersoli, Micol Tedeschi, Mara De Amici, Sara Manti, Valeria Brazzelli, Amelia Licari, Gian Luigi Marseglia   +11 more
wiley   +1 more source

Hypoallergenicity of a hydrolyzed rice protein-based formula containing 2-fucosyllactose and lacto-N-neotetraose in children with cow's milk allergy: protocol for a randomized controlled study. The RIGHT-HY study. [PDF]

Front Nutr
Zemrani B, Hays NP, D'Auria E, Mori F, Kalb B, Darwish N, Esposito S, Brzozowska A, Jedynak-Wasowicz U, Beyer K, Szajewska H, Canani RB.   +11 more
europepmc   +1 more source

Postbiotic effects elicited by heat-inactivated <i>Lacticaseibacillus rhamnosus GG</i> against cow's milk allergy in human cells. [PDF]

Front Immunol
Oglio F, Paparo L, Carucci L, Gaeta A, Armiento S, Coppola S, Molinaro A, De Castro C, Masino A, Mauriello V, Michelini M, Cozzolino M, Nocerino R, Pisapia L, Berni Canani R.   +14 more
europepmc   +1 more source

Severe Cow's Milk Allergy Presenting With Life-Threatening Metabolic Acidosis in an Extremely Preterm Infant: A Case Report. [PDF]

Cureus
Al Shafouri N, Khalid M, Al Muqarshi A, Al Hatmi J.   +3 more
europepmc   +1 more source

Five-Year Follow-Up Study of Single Dose Challenges in the Diagnosis and Management of Cow's Milk Allergy in Infants. [PDF]

Allergy
Corcoran A, d'Art Y, Byrne A, Hourihane JO.   +3 more
europepmc   +1 more source

Growth and safety of infants with cow's milk allergy receiving a new hydrolyzed rice protein-based formula containing 2-fucosyllactose and lacto-N-neotetraose: protocol for a randomized clinical trial. The RIGHT-GO study. [PDF]

Front Nutr
Zemrani B, Hays NP, Darwish N, Beyer K, Berni Canani R, Szajewska H, RIGHT-GO Consortium.   +6 more
europepmc   +1 more source